These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 15788494)
41. The effect of the European traditional use directive on the register of herbal medicinal products in Spain. Tejedor-García N; García-Pastor C; Navalmoral-Arenas E; Blas-Espada J; Madrigal-Martínez A; de Lucio-Cazaña FJ Gac Sanit; 2015; 29(3):221-3. PubMed ID: 25835515 [TBL] [Abstract][Full Text] [Related]
42. European perspective on garlic and its regulation. Kroes BH J Nutr; 2006 Mar; 136(3 Suppl):732S-735S. PubMed ID: 16484552 [TBL] [Abstract][Full Text] [Related]
43. [Herbal medicines in Spain: the current situation]. Blanché C Rev Esp Anestesiol Reanim; 2005 Oct; 52(8):451-2. PubMed ID: 16281739 [No Abstract] [Full Text] [Related]
44. Adverse effects associated with herbal medicine. Pinn G Aust Fam Physician; 2001 Nov; 30(11):1070-5. PubMed ID: 11759460 [TBL] [Abstract][Full Text] [Related]
45. Dosing botanical medicines. Yarnell E J Herb Pharmacother; 2005; 5(1):73-8. PubMed ID: 16093237 [No Abstract] [Full Text] [Related]
46. New regulatory rules for clinical trials in the United States and the European Union: key points and comparisons. Miossec M; Miossec P Arthritis Rheum; 2006 Dec; 54(12):3735-40. PubMed ID: 17133535 [No Abstract] [Full Text] [Related]
49. Are herbal remedies and dietary supplements safe and effective for breast cancer patients? Cassidy A Breast Cancer Res; 2003; 5(6):300-2. PubMed ID: 14580245 [TBL] [Abstract][Full Text] [Related]
50. [Herbal supplements in sports: use and abuse]. Caprino L; Braganò MC; Botrè F Ann Ist Super Sanita; 2005; 41(1):35-8. PubMed ID: 16037647 [TBL] [Abstract][Full Text] [Related]
51. Risking alternative and complementary medicine in the name of standardization. Kumar KJ; Bhatnagar SP J Altern Complement Med; 2006 Jun; 12(5):419-20. PubMed ID: 16813504 [No Abstract] [Full Text] [Related]
52. New European rules require all herbal medicines to be registered. Watson R BMJ; 2011 May; 342():d2815. PubMed ID: 21551180 [No Abstract] [Full Text] [Related]
53. Phytotherapy - new developments and insights into practice. Kraft K; Langhorst J Forsch Komplementmed; 2014; 21(6):345-6. PubMed ID: 25592944 [No Abstract] [Full Text] [Related]
54. Herbal drugs and public choice. McIntyre M; Lewith G; Flower A; Price S BMJ; 2014 Jun; 348():g4157. PubMed ID: 24961499 [No Abstract] [Full Text] [Related]
55. Kava update: a European perspective. Ernst E N Z Med J; 2004 Nov; 117(1205):U1143. PubMed ID: 15570327 [No Abstract] [Full Text] [Related]
56. Regulation of herbal drugs: a pragmatic public health approach? Cox AR BMJ; 2014 Jun; 348():g4156. PubMed ID: 24962966 [No Abstract] [Full Text] [Related]
58. Approaching the problem of bioequivalence of herbal medicinal products. Loew D; Kaszkin M Phytother Res; 2002 Dec; 16(8):705-11. PubMed ID: 12458470 [TBL] [Abstract][Full Text] [Related]
59. How the UK drug regulator became the herbalists' marketeer. McCartney M BMJ; 2014 May; 348():g3194. PubMed ID: 24816732 [No Abstract] [Full Text] [Related]
60. Innovation in Phytotherapy: Is a New Regulation the Feasible Perspective in Europe? Minghetti P; Franzè S; Zaccara V; Raso F; Morazzoni P Planta Med; 2016 May; 82(7):591-5. PubMed ID: 27135627 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]